Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19

Tocilizumab has been proposed as a means of opposing hyperinflammatory responses in intensive care patients with COVID-19. Here, we briefly discuss the potentially multiple, synergistic mechanisms whereby tocilizumab might exert therapeutic activity, mostly focusing on the production of tryptophan-d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Maria Laura Belladonna (Egilea), Ciriana Orabona (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2020-06-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!